How to Read a Peptide Certificate of Analysis
A Certificate of Analysis (COA) is the primary document that connects a peptide vial to the analytical evidence describing what is inside it. For a research buyer, it is the difference between a labelled assumption and a characterised material.
The difficulty is that COAs vary enormously in rigour. Two documents can carry the same “99% purity” headline while resting on completely different analytical foundations — or, in weaker cases, on no disclosed method at all. Reading a COA well means knowing which fields carry analytical weight, which are administrative, and which claims cannot be evaluated without a stated method.
This guide walks through a COA field by field, explains what each analytical technique actually demonstrates, and identifies the gaps that distinguish a substantive certificate from a decorative one.
What a Certificate of Analysis Is
A Certificate of Analysis is a document issued by a manufacturer or testing laboratory that reports the analytical results for a specific production batch of a material.
Three characteristics define a meaningful COA:
- It is batch-specific.A COA describes one lot, identified by a batch or lot number. A generic document describing “our peptides” is a specification sheet, not a certificate of analysis.
- It reports measured results, not targets.A specification states what a material should meet; a COA reports what the tested batch did Credible COAs frequently show both, side by side.
- It names its methods.A result without a stated analytical method cannot be independently interpreted.
The Standard Fields on a Peptide COA
Most peptide COAs follow a broadly similar layout. The table below maps the typical fields to what each one is actually for.
| Field | What it reports | Why it matters |
|---|---|---|
| Product / compound name | The peptide identity as designated by the manufacturer | Should match your order and the vial label exactly |
| Sequence | The amino acid sequence, typically in one-letter or three-letter code | Allows independent verification of identity and theoretical mass |
| Molecular formula | Elemental composition | Used to calculate theoretical molecular weight |
| Molecular weight | Theoretical mass, usually as average or monoisotopic | The reference value that mass spectrometry results are compared against |
| CAS number | Chemical Abstracts registry identifier, where one exists | Useful for cross-referencing; not all research peptides have one |
| Batch / lot number | The specific production lot | The link between the document and the physical vial |
| Appearance | Observed physical form (e.g. white to off-white lyophilised powder) | A basic visual conformity check |
| Purity | The measured purity result, with method | The headline analytical figure — only interpretable with its method |
| Analytical method(s) | The techniques used (e.g. RP-HPLC, mass spectrometry) | Determines what the reported figures actually prove |
| Peptide content | The proportion of the powder that is peptide, as distinct from purity | Frequently omitted; see the section below |
| Water / moisture content | Residual water, often by Karl Fischer titration | Affects mass accuracy and stability considerations |
| Counter-ion / salt form | e.g. acetate or trifluoroacetate (TFA) | Contributes to total mass, relevant to formulation work |
| Storage conditions | Recommended storage for the material | Supports handling and stability planning |
| Test date / release date | When the analysis was performed | Establishes the age of the analytical data |
| Authorised signature | The person or laboratory releasing the results | Accountability for the reported data |
Not every COA includes every field. Absences are informative: a COA lacking a batch number, a stated method, or a test date is materially weaker than one that includes them.
Purity Is Not the Same as Peptide Content
This is the distinction most often missing from vendor-published explanations, and it changes how a “99%” figure should be read.
Purity describes the peptide fraction relative to other peptide-related species — truncated sequences, deletion sequences, and synthesis by-products. It is typically measured chromatographically and expressed as the percentage of total peak area attributable to the target peptide.
Peptide content (sometimes called peptide load) describes how much of the lyophilised powder in the vial is actually peptide, as opposed to residual water, counter-ions such as acetate or TFA, and other non-peptide residues.
These measure different things:
- A batch can report high chromatographic purity while a substantial share of the vial’s mass is water and salt.
- Purity says nothing about the mass of peptide you are weighing out.
- Quantitative work — anything where the actual amount of peptide matters — depends on peptide content, not purity alone.
Peptide content is commonly determined by amino acid analysis (AAA) or by nitrogen determination. Many research-grade COAs omit it. Its absence is not automatically a defect, but for quantitative experimental design it is a genuine limitation, and it is reasonable to request it.
What Each Analytical Method Actually Proves
A purity percentage is only as meaningful as the method behind it. Different techniques answer different questions, and no single method answers all of them.
| Method | What it demonstrates | What it does not demonstrate |
|---|---|---|
| RP-HPLC (reversed-phase high-performance liquid chromatography) | Separates the sample into components and quantifies relative abundance, typically by UV peak area — the usual basis of a purity percentage | Does not confirm identity; co-eluting species may not resolve into separate peaks |
| Mass spectrometry (e.g. ESI-MS, MALDI-TOF) | Measures molecular mass, confirming the observed mass is consistent with the expected sequence — an identity check | Is not, on its own, a quantitative purity measurement |
| LC-MS (liquid chromatography–mass spectrometry) | Couples separation with mass detection, allowing separated components to be mass-identified | Interpretation depends on method parameters; still requires appropriate validation |
| Amino acid analysis (AAA) | Quantifies amino acid composition; used to determine peptide content | Does not assess sequence order or chromatographic purity |
| Karl Fischer titration | Quantifies residual water content | Says nothing about purity or identity |
The practical consequence: HPLC and mass spectrometry are complementary, not interchangeable. HPLC addresses “how much of this is the target species?” Mass spectrometry addresses “is this the species we think it is?” A COA reporting both provides materially stronger characterisation than one reporting either alone.
Why a Purity Figure Without a Method Is Uninterpretable
A percentage is the output of a procedure. Without knowing the procedure, the number cannot be evaluated. At minimum, a substantive purity claim should be accompanied by:
- The technique used (e.g. RP-HPLC)
- The detection wavelength, where UV detection is used (214 nm and 220 nm are commonly used for peptide bonds; 280 nm responds to aromatic residues)
- Sufficient method detail to make the result interpretable — gradient, column, and mobile phase where available
Detection wavelength is not a trivial footnote. Because different wavelengths respond to different structural features, the same sample can yield different apparent purity values depending on the detection conditions. This is a normal analytical reality, not evidence of misconduct — but it is a reason that “99%” without context is an incomplete claim.
Reading the Chromatogram
Many COAs attach the underlying chromatogram. Where one is provided, it is worth examining rather than accepting the summary figure alone.
- The main peakshould be clearly dominant and well resolved from neighbouring peaks.
- Baseline separationbetween the target peak and adjacent impurity peaks supports the reliability of the integration.
- Peak shapematters — pronounced tailing or fronting can complicate integration and affect the reported percentage.
- Integration boundariesdetermine what was counted. Where the integration region is visible, it indicates how the percentage was derived.
- Axis labels and run conditionsshould be legible. An unlabelled, low-resolution chromatogram image contributes little verifiable information.
An attached chromatogram that cannot be read is closer to decoration than evidence. A legible one allows a reviewer to form an independent view of the reported number.
Cross-Checking the COA Against the Vial
A COA is only meaningful if it corresponds to the material received. A short verification sequence:
- Batch number match.The lot number on the COA should match the vial label exactly. If it does not, the document does not describe your material.
- Compound name and sequence match.Confirm the peptide name and, where listed, the sequence match what was ordered.
- Molecular weight consistency.The stated molecular weight should be consistent with the sequence and formula given. Where mass spectrometry data is included, the observed mass should be consistent with the theoretical mass.
- Appearance.The physical form should be consistent with the description on the certificate.
- Test date present.Analytical data should carry a date establishing when the testing occurred.
Discrepancies in any of these are grounds to contact the supplier for clarification before use.
Red Flags in a Peptide COA
The following patterns indicate a document with limited analytical value. None is proof of misconduct on its own; together they describe a weak certificate.
- No batch or lot number.Without it, the document cannot be tied to a specific production run.
- A purity figure with no stated method.An uninterpretable number.
- No test date.The age and relevance of the data cannot be established.
- Identical documents across different products or batches.Suggests a template rather than batch-specific testing.
- An illegible or absent chromatogramwhere one is implied to support the result.
- Round-number purity claims with no supporting data— for example, a bare “99%” with no method, no chromatogram, and no detection conditions.
- No identifiable issuing party.No laboratory name, no signature, no accountable source.
- Purity presented as if it were peptide content, or the two used interchangeably.
- Therapeutic or medical language on a research document.A COA is an analytical record. Claims about effects or applications do not belong on one and signal a document written for marketing rather than characterisation.
What a COA Does Not Tell You
Equally important is understanding the limits of the document. A COA does not establish:
- Suitability for any particular application.It characterises material; it does not validate an experimental design.
- Stability over time.Results describe the material at the time of testing. Subsequent handling, shipping, and storage conditions affect the material but are not captured by the certificate.
- Sterility or endotoxin status, unless those tests are specifically reported.
- Anything about human or veterinary use.Research materials characterised by a COA are not approved or evaluated for use in humans or animals. Analytical characterisation and regulatory approval for medical use are entirely separate matters, and a COA speaks only to the former.
Independent Testing and Why It Is Treated Separately
A COA may be issued by the manufacturer’s internal quality function or by an independent third-party laboratory. Both can be legitimate. The distinction matters because independent testing removes the commercial interest of the producing party from the result.
Where a certificate originates from a third-party laboratory, the laboratory should be identifiable on the document. Where it is issued in-house, that is normal practice and should simply be understood for what it is. Transparency about which is which is itself a quality signal.
A Short Glossary of COA Terminology
| Term | Meaning |
|---|---|
| Lot / batch | A quantity of material produced in a single manufacturing run under uniform conditions |
| RP-HPLC | Reversed-phase HPLC; a chromatographic separation technique widely used for peptide purity analysis |
| ESI-MS / MALDI-TOF | Mass spectrometry techniques used to determine molecular mass |
| Term | Meaning |
|---|---|
| for identity confirmation | |
| Monoisotopic mass | Mass calculated using the most abundant isotope of each element |
| Average mass | Mass calculated using the average atomic weights of the elements |
| Counter-ion | The salt form associated with the peptide, commonly acetate or trifluoroacetate (TFA) |
| Lyophilised | Freeze-dried; the typical physical form of research peptides |
| Peptide content | The proportion of the powder that is peptide, excluding water, salts, and other residues |
| Karl Fischer titration | An analytical method for determining water content |
| Specification | The criteria a material is intended to meet, as distinct from measured batch results |
Frequently Asked Research Questions
What is a Certificate of Analysis for a peptide?
A COA is a batch-specific document reporting the analytical test results for one production lot of a peptide, including the identity, purity, and the methods used to obtain those results. It is distinct from a specification sheet, which states intended criteria rather than measured outcomes.
What does 99% purity on a peptide COA actually mean?
A COA is a batch-specific document reporting the analytical test results for one production lot of a peptide, including the identity, purity, and the methods used to obtain those results. It is distinct from a specification sheet, which states intended criteria rather than measured outcomes.
What is the difference between peptide purity and peptide content?
Purity is the proportion of the peptide fraction that is the target species relative to other peptide-related impurities. Peptide content is the proportion of the total powder mass that is peptide, as opposed to water, counter-ions, and other residues. A batch can show high purity while peptide content is considerably lower.
Is HPLC or mass spectrometry more important on a COA?
They serve different purposes and are best read together. HPLC quantifies relative abundance and underpins the purity figure. Mass spectrometry confirms that the measured molecular mass is consistent with the expected sequence, supporting identity. Neither substitutes for the other.
Should a COA be batch-specific?
Yes. A document that does not identify a specific lot cannot be matched to the material received and functions as a general specification rather than a certificate of analysis.
Does a COA confirm that a peptide is safe?
No. A COA reports analytical characteristics such as identity and purity. It does not establish safety, does not assess suitability for any application, and has no bearing on human or veterinary use. Research materials are not evaluated or approved for medical use.
What should I do if the batch number on the COA does not match the vial?
Treat the document as not describing your material and contact the supplier for the correct batch-specific certificate before proceeding.
How long does a COA remain valid?
A COA reports results as of the test date. It is a record of the material at the point of analysis, not a guarantee of ongoing condition; storage and handling after testing affect the material independently of the certificate.
Reviewing Documentation for Your Own Research Materials
Reading a COA well is a repeatable skill: confirm the document is batch-specific, check that every reported figure names its method, distinguish purity from peptide content, and treat unexplained numbers as unverified rather than as evidence.
Researchers evaluating suppliers can review the batch documentation and analytical specifications published for each compound in the Everclear Peptides research catalogue, or contact the research support team with documentation questions relating to a specific lot.